MENA Generic Oncology Drug Market Growth, Trends and Forecast to 2032

a adăugat un sunet Alte

2024-09-24 12:45:49 - Translate

According to a new report by Univdatos Market Insights, the MENA Generic Oncology Drug Market is expected to reach USD 7.5 Billion in 2032 by growing at a CAGR of 3%. The Middle East and North Africa (MENA) region is witnessing a notable surge in the demand for oncology drugs, driven by the increasing prevalence of cancer and the need for affordable treatment options. Within this landscape,...

0 Commentarii 0 Distribuiri 325 Views 0 previzualizare